References
- Tan Q, Guo Q, Fang C, Wang C, Li B, Wang H, et al. Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein products. MAbs 2012; 4:761 - 74; http://dx.doi.org/10.4161/mabs.22276; PMID: 23032066
- Lee JF, Litten JB, Grampp G. Comparability and biosimilarity: considerations for the healthcare provider. Curr Med Res Opin 2012; 28:1053 - 8; http://dx.doi.org/10.1185/03007995.2012.686902; PMID: 22519391
- Views on Public Policy. Biosimilars [Internet]. San Francisco (CA); Genentech: c2013 [cited 2013 May 28]. Available from: http://www.gene.com/about-us/views-on-public-policy/biosimilars.
- Refusal assessment report for Alpheon [Internet]. London (UK); European Medicines Agency; c2006 [cited 2013 May 28]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/ EPAR_-_Public_assessment_report/human/000585/WC500070792.pdf.